This is the authors' abstract. We don't add key points for this paper.
The NLRP3 inflammasome is a key regulator of inflammatory responses and is increasingly recognized as an important mediator of pathological reactions to diverse chemical, biological, and microenvironmental stimuli. However, most currently available approaches primarily detect downstream or end-stage events, limiting real-time analysis of the early molecular processes that precede inflammasome assembly. Here, we report NEKfla, a genetically encoded Förster resonance energy transfer (FRET)-based biosensor designed to monitor early NEK7-NLRP3-associated signaling in living cells with single-cell spatiotemporal resolution. NEKfla was engineered using full-length NEK7 and NLRP3 linked to a ECFP-YPet FRET pair, and a ΔLRR control sensor was generated to assess interaction-dependent responses. In live-cell and in vitro analyses, NEKfla detected stimulus-dependent increases in FRET in response to lipopolysaccharide and nigericin, responded to pharmacological inhibition by MCC950 and licochalcone B, and visualized dynamic changes associated with NLRP3 oligomerization. The biosensor also functioned in multiple cellular contexts, including macrophage-like cells, and detected signaling changes earlier than a caspase-1 reporter. Together, these findings establish NEKfla as a live-cell platform for tracking proximal inflammasome activation events and support its potential utility in mechanistic studies and cell-based screening of materials or compounds that modulate early NLRP3 inflammasome signaling.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: